OPKO Health's (OPK) CEO Phillip Frost on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 07/31/20
OPKO Health Reports 2020 Second Quarter Business Highlights and Financial ResultsGlobeNewsWire • 07/30/20
Got $2,000 in Cash? Put It Into This Company Testing for Coronavirus in Pro SportsThe Motley Fool • 07/28/20
OPKO Health's BioReference Laboratories Awarded Commercial Surge Capacity Testing for COVID-19 Emergency Response Contract by Centers for Disease Control and Prevention (CDC)PRNewsWire • 07/20/20
OPKO Health's BioReference Laboratories Reports Results of COVID-19 Testing for Almost One Quarter of a Million Nursing Home and Live-in Facility EmployeesPRNewsWire • 07/01/20
OPKO Health, Inc. (OPK) CEO Phillip Frost Hosts 2020 Annual Meeting of Stockholders (Transcript)Seeking Alpha • 06/25/20
OPKO Health Announces Positive Top-Line Results of Phase 3 Efficacy and Safety Study of Somatrogon for the Treatment of Japanese Children with Growth Hormone DeficiencyGlobeNewsWire • 06/09/20
OPKO Health (OPK) Up 16.4% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 06/05/20